Table 2 Univariate regression and multivariable regression analysis results

FH screened by FAMCAT

–

0.142 (0 - Inf)

0.878

0.50 (0.00 - Inf)

0.951

 0–1 dose

1089

Ref

ref

 2 doses

1421

0.60 (0.47–0.79)

<0.001**

0.68 (0.52–0.89)

0.004*

 ≥3 doses

1368

0.49 (0.35–0.68)

<0.001***

0.56 (0.40–0.78)

<0.001**

Healthcare utilisation within 2 years

–

0.94 (0.92–0.97)

<0.001***

0.95 (0.92–0.97)

<0.001**

COVID-19 associated hospitalisation

360

1.66 (1.22–2.26)

0.001*

1.41 (1.03–1.93)

0.035*

Charlson Comorbidity Index

–

1.10 (1.02–1.19)

0.018*

1.04 (0.95–1.14)

0.365

Peripheral vascular disease

28

3.62 (1.62–8.10)

0.002*

2.98 (1.31–6.79)

0.009*

Hypertension

1794

0.83 (0.67–1.01)

0.062

1.01 (0.80–1.29)

0.913

Type 2 diabetes

862

1.13 (0.89–1.43)

0.323

1.16 (0.89–1.51)

0.275

Mental disorders

340

1.20 (0.86–1.68)

0.291

1.09 (0.77–1.54)

0.628